3M kauft Acelity Medizintechnik für 6,7 Mrd. $.
"...On a GAAP reported basis, 3M estimates the acquisition to be $0.35 dilutive to earnings per share in the first 12 months following completion of the transaction, including financing costs. Excluding purchase accounting adjustments and anticipated one-time expenses related to the transaction and integration, 3M estimates the acquisition to be $0.25 accretive to earnings per share over the same period. ...
... As a result of this announcement, 3M now expects full-year 2019 share repurchases to be in the range of $1.0 billion to $1.5 billion versus $2.0 billion to $4.0 billion previously. ...
3M will finance the transaction with a combination of available cash and proceeds from the issuance of new debt."
https://investors.3m.com/news/press-rele...fault.aspx
3M reagiert also auf die übersichtlichen Quartalszahlen u.a. mit Reorganisation, Kosteneinsparungen (2000 Jobs) und M&A, um das Schiff wieder unter Dampf zu setzen!
"...On a GAAP reported basis, 3M estimates the acquisition to be $0.35 dilutive to earnings per share in the first 12 months following completion of the transaction, including financing costs. Excluding purchase accounting adjustments and anticipated one-time expenses related to the transaction and integration, 3M estimates the acquisition to be $0.25 accretive to earnings per share over the same period. ...
... As a result of this announcement, 3M now expects full-year 2019 share repurchases to be in the range of $1.0 billion to $1.5 billion versus $2.0 billion to $4.0 billion previously. ...
3M will finance the transaction with a combination of available cash and proceeds from the issuance of new debt."
https://investors.3m.com/news/press-rele...fault.aspx
3M reagiert also auf die übersichtlichen Quartalszahlen u.a. mit Reorganisation, Kosteneinsparungen (2000 Jobs) und M&A, um das Schiff wieder unter Dampf zu setzen!
